drugset / Trial / NCT06675422
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
Phase 1/2
Recruiting
20 enrolled
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
NaSingle-groupOpen-labelTreatment
Summary
Early exploratory clinical study of the safety, tolerability and initial efficacy of JY231 injection in the treatment of active systemic lupus erythematosus (SLE)
Timeline
- Start
- 2024-10-09
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JY231 | Cell therapy | — | Intravenous |